CIBERERCentre for Biomedical Network Research on Rare Diseases (est. 2006)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
SGR 2014/376]; InterCiber PIE1400061 and CIBER de Enfermedades Raras (CIBERER, an initiative of ISCIII).
(1) Muscle Research and Mitochondrial Function Laboratory, Cellex-IDIBAPS, Faculty of Medicine and Health Sciences, University of Barcelona, Internal Medicine Department, Hospital Clinic of Barcelona, CIBERER U722, Barcelona, Spain
[1] Human Cancer Genetics Programme and [6] Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; [2] Pathology Service and [7] Medical Oncology Service, Hospital Virgen de la Macarena, Sevilla, Spain; [3] Projects Unit, Sistemas Genomicos, Valencia, Spain; [4] Surgery Service and [5] Pathology Service, Hospital Monte Naranco, Oviedo, Spain; [8] Spanish Network in Rare Diseases (CIBERER), Madrid, Spain; [9] Molecular Genetics Unit, Research Institute of Rare Diseases (IIER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Washington, April 26 ( ANI ): An international team of scientists led by the Universitat Autonoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered.
CIBERER es una iniciativa del Instituto de Salud Carlos III.
Pallardo are supported by the Ministry of Economy and Competitiveness and the Institute of Health Carlos III through CIBERER (the Center for Biomedical Network Research on Rare Diseases and the Ingenio 2010 Initiative cofinanced by FEDER funds from the European Union), as well as by grants from the University of Valencia (1090569000) and the Spanish National Plan for Scientific and Technical Research and Innovation (AIB2010-SE-00333).
The CIBER of Rare Diseases (CIBERER) is an initiative of the ISCIII, Spain.
[1] Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Spain; [2] Bioinformatics and Biostatistics Unit, Department of Epidemiology, IDIBELL-Institut Catala d'Oncologia, Barcelona, Spain; [3] Human Genetics Group, Spanish National Cancer Centre (CNIO), and Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III, CIBERER; [4]Genetic Counselling Unit, IDIBELL-Institut Catala d'Oncologia, Barcelona, Spain; [5] Department of Genetics, INSERM U614, Faculty of Medicine, Rouen, France.